IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
09 02 2021
Historique:
entrez: 2 2 2021
pubmed: 3 2 2021
medline: 25 6 2021
Statut: ppublish

Résumé

A hallmark of cancer, including pancreatic ductal adenocarcinoma (PDA), is a massive stromal and inflammatory reaction. Many efforts have been made to identify the anti- or protumoral role of cytokines and immune subpopulations within the stroma. Here, we investigated the role of interleukin-17A (IL17A) and its effect on tumor fibroblasts and the tumor microenvironment. We used a spontaneous PDA mouse model (KPC) crossed to IL17A knockout mice to show an extensive desmoplastic reaction, without impaired immune infiltration. Macrophages, especially CD80

Identifiants

pubmed: 33526692
pii: 2020395118
doi: 10.1073/pnas.2020395118
pmc: PMC8017922
pii:
doi:

Substances chimiques

Forkhead Transcription Factors 0
Foxp3 protein, mouse 0
Il17a protein, mouse 0
Il17rc protein, mouse 0
Interleukin-17 0
Receptors, Interleukin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

J Clin Invest. 2020 Sep 1;130(9):4704-4709
pubmed: 32749238
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3604-3613
pubmed: 30733286
Microsc Res Tech. 2009 Jun;72(6):411-23
pubmed: 19208388
Pancreas. 2004 Jan;28(1):e26-31
pubmed: 14707745
Gastroenterology. 2018 Jul;155(1):210-223.e3
pubmed: 29604293
Thorac Cancer. 2020 Jan;11(1):120-129
pubmed: 31760702
PLoS One. 2017 Nov 30;12(11):e0188870
pubmed: 29190794
J Exp Med. 2020 Dec 7;217(12):
pubmed: 32860704
Oncotarget. 2016 Nov 15;7(46):76197-76213
pubmed: 27776346
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
Cancer Lett. 2009 Jun 28;279(1):1-7
pubmed: 19013709
Gastroenterology. 2013 May;144(5):1098-106
pubmed: 23333712
Mech Ageing Dev. 2011 Oct;132(10):468-79
pubmed: 21820463
Cancer Cell. 2014 Jun 16;25(6):719-34
pubmed: 24856586
Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5549s-5555s
pubmed: 17875788
Cancer Cell. 2014 Jun 16;25(6):735-47
pubmed: 24856585
Cancer Cell. 2014 May 12;25(5):621-37
pubmed: 24823639
J Exp Med. 2015 Mar 9;212(3):333-49
pubmed: 25732306
Gut. 2017 Nov;66(11):1995-2007
pubmed: 27464707
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4326-4335
pubmed: 30770442
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
Cancer Cell. 2020 Mar 16;37(3):289-307.e9
pubmed: 32183949
Immunity. 2002 Sep;17(3):375-87
pubmed: 12354389
Gastroenterology. 2018 Mar;154(4):820-838
pubmed: 29287624
Cancer Discov. 2019 Aug;9(8):1102-1123
pubmed: 31197017
Oncoimmunology. 2017 Nov 13;7(2):e1393596
pubmed: 29308326
BMC Cancer. 2014 Jul 09;14:499
pubmed: 25011545
Growth Horm IGF Res. 2005 Jun;15(3):185-92
pubmed: 15914054
Cancer Immunol Immunother. 2013 Jul;62(7):1249-60
pubmed: 23640603
Cancer Microenviron. 2015 Dec;8(3):159-66
pubmed: 25106539
Clin Gastroenterol Hepatol. 2008 Oct;6(10):1155-61
pubmed: 18639493
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
HPB (Oxford). 2015 Apr;17(4):292-8
pubmed: 25250696
J Clin Invest. 2016 Nov 1;126(11):4140-4156
pubmed: 27701147
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Gastroenterology. 2015 Jul;149(1):201-10
pubmed: 25888329
Cancer Immunol Immunother. 2018 Jun;67(6):981-988
pubmed: 28884365
Gastroenterology. 2013 Jun;144(6):1210-9
pubmed: 23622130
Br J Cancer. 2014 Nov 11;111(10):1917-23
pubmed: 25314063
Cancer Res. 2003 Dec 15;63(24):8912-21
pubmed: 14695208
Gut. 2015 Sep;64(9):1476-84
pubmed: 25994217

Auteurs

Gianluca Mucciolo (G)

Laboratory of Tumor Immunology, Center for Experimental Research and Medical Studies, Città della Salute e della Scienza di Torino, University of Torino, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.

Claudia Curcio (C)

Laboratory of Tumor Immunology, Center for Experimental Research and Medical Studies, Città della Salute e della Scienza di Torino, University of Torino, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.

Cecilia Roux (C)

Laboratory of Tumor Immunology, Center for Experimental Research and Medical Studies, Città della Salute e della Scienza di Torino, University of Torino, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.

Wanda Y Li (WY)

Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.

Michela Capello (M)

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

Roberta Curto (R)

Laboratory of Tumor Immunology, Center for Experimental Research and Medical Studies, Città della Salute e della Scienza di Torino, University of Torino, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.

Roberto Chiarle (R)

Laboratory of Tumor Immunology, Center for Experimental Research and Medical Studies, Città della Salute e della Scienza di Torino, University of Torino, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115.

Daniele Giordano (D)

Laboratory of Tumor Immunology, Center for Experimental Research and Medical Studies, Città della Salute e della Scienza di Torino, University of Torino, 10126 Torino, Italy.

Maria Antonietta Satolli (MA)

Medical Oncology Division, Centro Oncologico Ematologico Subalpino, Città della Salute e della Scienza di Torino, Department of Oncology, University of Torino, 10126 Torino, Italy.

Rita Lawlor (R)

Applied Research Center (ARC-NET), University of Verona, 37134 Verona, Italy.
Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.

Aldo Scarpa (A)

Applied Research Center (ARC-NET), University of Verona, 37134 Verona, Italy.
Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.

Pavol Lukac (P)

Laboratory of Immunotherapy, Institute of Microbiology v.v.i., Czech Academy of Sciences, Prague 14220, Czech Republic.
Faculty of Science, Charles University, Prague 12800, Czech Republic.

Dmitry Stakheev (D)

Laboratory of Immunotherapy, Institute of Microbiology v.v.i., Czech Academy of Sciences, Prague 14220, Czech Republic.
Faculty of Medicine, Charles University, Prague 12108, Czech Republic.

Paolo Provero (P)

Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.

Luca Vannucci (L)

Laboratory of Immunotherapy, Institute of Microbiology v.v.i., Czech Academy of Sciences, Prague 14220, Czech Republic.

Tak W Mak (TW)

Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada; tak.mak@uhnresearch.ca franco.novelli@unito.it paola.cappello@unito.it.
Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Department of Medicine, University of Hong Kong, 999077 Hong Kong.

Francesco Novelli (F)

Laboratory of Tumor Immunology, Center for Experimental Research and Medical Studies, Città della Salute e della Scienza di Torino, University of Torino, 10126 Torino, Italy; tak.mak@uhnresearch.ca franco.novelli@unito.it paola.cappello@unito.it.
Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy.

Paola Cappello (P)

Laboratory of Tumor Immunology, Center for Experimental Research and Medical Studies, Città della Salute e della Scienza di Torino, University of Torino, 10126 Torino, Italy; tak.mak@uhnresearch.ca franco.novelli@unito.it paola.cappello@unito.it.
Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH